PHARMACYTE BIOTECH, INC. (PMCB)

Import this data to Google Sheets with:

=jivedata("PMCB","financials")

Full statements spill as a table. For one cell: =jivedata("PMCB","Revenue") or =jivedata("PMCB","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

PHARMACYTE BIOTECH, INC.

PMCB • CIK 0001157075

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenues	$0	$0	$0	$0
Operating Expenses	$8,520.008	$4,377.862	$6,853.713	$7,012.116
Operating Income (Loss)	$-8,520.008	$-4,377.862	$-6,853.713	$-7,012.116
Nonoperating Income (Expense)	$8,853.771	$35,033.912	$-12,570.941	$-9,133.633
Net Income (Loss) Attributable to Parent	$333.763	$30,656.05	$-19,424.654	$-16,145.749
Dividends, Preferred Stock	$2,517.645	$1,129.759	$278.496	$361.895
Preferred Stock, Accretion of Redemption Discount	$15,053.521	$3,193.404	$3,503.222	$4,124.439
Net Income (Loss) Available to Common Stockholders, Basic	$-17,237.403	$23,362.107	$-23,206.372	$-20,632.083
Weighted Average Number of Shares Outstanding, Basic	9,581,059	7,329,596	8,378,291	12,318,161
Research and Development Expense	$407.431	$438.416	$391.301	$356.144
Impairment of Intangible Assets (Excluding Goodwill)	$2,000	$0	$1,549.427	$1,549.427
General and Administrative Expense	$2,117.322	$3,939.446	$4,912.985	$5,106.545
Interest Income, Other	$3,398.819	$1,415.561	$733.351	$681.836
Dividend Income, Operating	—	—	$380.682	$621.566
Marketable Securities, Unrealized Gain (Loss)	—	$66.316	$-412.306	$-462.391
Gain (Loss) on Disposition of Oil and Gas and Timber Property	—	$-2,019	$0	$0
Other Nonoperating Income (Expense)	$191.145	$-0.965	$-0.98	$-0.956
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	—	$23,362.107	$-23,206.372	$-20,632.083
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	23,261,116	19,740,808	61,988,207	103,579,356

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Assets	$59,903.883	$55,168.353	$46,753.242	$36,712.295
Other Accrued Liabilities, Noncurrent	—	$25	$0	$0
Derivative Liability, Noncurrent	$2,184	$0	$878	$281
Other Liabilities	$12,968	$363	$10,946	$6,128
Liabilities	$20,389.264	$3,277.284	$11,772.424	$6,896.682
Stockholders' Equity Attributable to Parent	$27,647.603	$51,891.069	$33,294.926	$27,508.504
Assets, Current	$50,439.768	$22,375.238	$37,420.554	$30,974.607
Other Assets, Noncurrent	—	—	$7.688	$7.688
Assets, Noncurrent	$9,464.115	$32,793.115	$9,332.688	$5,737.688
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2.167	$2.167	$2.602	$2.602
Additional Paid in Capital	$185,334.173	$181,489.647	$182,716.275	$182,011.659
Retained Earnings (Accumulated Deficit)	$-115,625.01	$-84,968.96	$-104,393.614	$-109,474.805
Treasury Stock, Common, Value	$42,040.216	$44,607.916	$45,009.541	$45,009.541
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-23.511	$-23.869	$-20.796	$-21.411
Cash and Cash Equivalents, at Carrying Value	$50,179.968	$15,172.163	$18,603.899	$17,738.991
Marketable Securities, Current	—	$366.316	$254.01	$99.462
Dividends Receivable	—	—	$240.766	$429.15
Prepaid Expense and Other Assets, Current	$259.8	$223.759	$96.879	$32.004
Intangible Assets, Net (Excluding Goodwill)	$1,549.427	$1,549.427	$0	$0
Investments	—	—	$0	$0
Accounts Payable, Current	$389.369	$399.204	$271.102	$390.535
Accrued Liabilities, Current	$735.199	$2,515.08	$522.831	$345.656
Dividends Payable, Current	$6,296.696	$0	$32.491	$32.491
Liabilities, Current	$7,421.264	$2,914.284	$826.424	$768.682
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	21,672,078	21,672,095	26,005,715	26,005,715
Common Stock, Shares, Outstanding	8,037,624	6,795,779	10,735,649	10,735,649
Treasury Stock, Common, Shares	13,634,454	14,876,316	15,270,066	15,270,066

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss) Attributable to Parent	$333.763	$30,656.05	$-19,424.654	$-16,145.749
Impairment of Intangible Assets (Excluding Goodwill)	$2,000	$0	$1,549.427	$1,549.427
Share-based Payment Arrangement, Noncash Expense	$0	$478.637	$892.5	$892.5
Marketable Securities, Unrealized Gain (Loss)	—	$66.316	$-412.306	$-462.391
Increase (Decrease) in Prepaid Expense and Other Assets	$152.119	$-36.041	$251.386	$360.474
Increase (Decrease) in Other Accounts Payable	$261.09	$9.835	$-128.102	$-74.674
Increase (Decrease) in Other Accrued Liabilities	$189.923	$1,310.457	$-1,548.249	$-719
Net Cash Provided by (Used in) Operating Activities	$-2,151.457	$-2,978.296	$-5,152.914	$-3,939.827
Net Cash Provided by (Used in) Investing Activities	$-5,000	$-7,000	$2,000	$2,000
Payments for Repurchase of Common Stock	$28,197.617	$2,542.276	$401.625	$401.625
Proceeds from Issuance of Convertible Preferred Stock	—	—	$6,182.447	$6,182.447
Proceeds from Warrant Exercises	$0.07	$0	$1,046.76	$1,046.76
Net Cash Provided by (Used in) Financing Activities	$-10,708.003	$-25,029.151	$6,581.577	$6,498.178
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-0.508	$-0.358	$3.073	$2.335
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-17,859.968	$-35,007.805	$3,431.736	$4,560.686
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$50,179.968	$15,172.163	$18,603.899	$23,164.585
Income Taxes Paid, Net	$1.6	$0	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PMCB","financials")

Full statements spill as a table. For one cell: =jivedata("PMCB","Revenue") or =jivedata("PMCB","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.